Jubilant Pharmova Ltd (JUBLPHARMA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 530019 | NSE: JUBLPHARMA | Pharmaceuticals & Drugs | Small Cap

Jubilant Pharmova Share Price

1,076.40 7.20 0.67%
as on 05-Dec'25 16:59

Jubilant Pharmova Ltd (JUBLPHARMA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 530019 | NSE: JUBLPHARMA | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Jubilant Pharmova

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Jubilant Pharmova stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
17,030.3 Cr.
52-wk low:
823.7
52-wk high:
1,250

Is Jubilant Pharmova Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Jubilant Pharmova: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Jubilant Pharmova Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 7.1%7.6%13.6%8.1%10.1%11.8%4.4%3.7%2.6%2.5%-
Value Creation
Index
-0.5-0.40.0-0.4-0.3-0.1-0.7-0.7-0.8-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2,6562,4913,3063,4393,1402,710726810785746535
Sales YoY Gr.--6.2%32.7%4%-8.7%-13.7%-73.2%11.6%-3.1%-5%-
Adj EPS 4.84.816.110.320.613.55.13.121.8-1.6
YoY Gr.-0.2%234.6%-35.7%99.4%-34.6%-62%-39.8%-33.8%-14.2%-
BVPS (₹) 126.3128.2141.2146.9163.780.5153.1151.6148.6145140.9
Adj Net
Profit
76.476.425616532821581.649.132.527.8-25
Cash Flow from Ops. 164419558182317608-3.6-65.1143136-
Debt/CF from Ops. 114.12.69.46.20.8-49-4.62.42.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -13.2%-25%0.9%-5%
Adj EPS -10.6%-38.9%-30.1%-14.2%
BVPS1.6%-2.4%-1.8%-2.4%
Share Price 9.5% 5.6% 42.1% -10.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
3.93.811.97.213.3114.421.41.2-1.1
Op. Profit
Mgn %
11.91316.41012.115.81.10.42.34.511.1
Net Profit
Mgn %
2.93.17.74.810.57.911.26.14.13.7-4.7
Debt to
Equity
0.90.80.60.70.80.40.10.10.20.10
Working Cap
Days
19515413313916110213925026225769
Cash Conv.
Cycle
4044232841246713614213715

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Jubilant Pharmova Ltd.

Standalone Consolidated
TTM EPS (₹) -1.6 30
TTM Sales (₹ Cr.) 535 7,566
BVPS (₹.) 140.9 413.8
Reserves (₹ Cr.) 2,228 6,576
P/BV 7.59 2.58
PE 0.00 35.65
From the Market
52 Week Low / High (₹) 823.70 / 1250.00
All Time Low / High (₹) 3.51 / 1309.00
Market Cap (₹ Cr.) 17,030
Equity (₹ Cr.) 15.9
Face Value (₹) 1
Industry PE 40.7

Management X-Ray of Jubilant Pharmova:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.005.40
* Pledged shares as % of Promoter's holding (%)

Valuation of Jubilant Pharmova - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Jubilant Pharmova

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales2,6562,4913,3063,4393,1402,709726810785746
Operating Expenses 2,3442,1732,7673,1182,7692,282719807768714
Manufacturing Costs513475568617640499103125129140
Material Costs1,4531,3101,7712,0531,6841,450332415356276
Employee Cost 216226264266265221164167190203
Other Costs 1621621631831791131211009495
Operating Profit 312318539321371427631732
Operating Profit Margin (%) 11.8%12.8%16.3%9.3%11.8%15.8%0.9%0.4%2.1%4.3%
Other Income 6252467817348126138103100
Interest 20117413512913610211193030
Depreciation 8781838610710037434853
Exceptional Items 0000-20000-11
Profit Before Tax 8611536818329927385794238
Tax 133510436-22594291018
Profit After Tax 737926314832121480503219
PAT Margin (%) 2.7%3.2%8.0%4.3%10.2%7.9%11.1%6.2%4.0%2.6%
Adjusted EPS (₹)4.65.016.59.320.213.55.13.12.01.2
Dividend Payout Ratio (%)65%60%18%49%25%37%99%159%252%414%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 2,0142,0422,2492,3402,6071,2822,4392,4112,3622,305
Share Capital 16161616161616161616
Reserves 1,9982,0262,2332,3242,5911,2672,4232,3952,3462,289
Minority Interest0000000000
Debt1,5691,5641,2501,6021,951493174302340292
Long Term Debt1,1151,3871,0591,1401,328420174174247233
Short Term Debt4541771914636237301289460
Trade Payables36448774959661916159164148155
Others Liabilities 3592883763252575389115129146
Total Liabilities 4,3064,3824,6254,8645,4331,8452,8602,9912,9802,898

Fixed Assets

Gross Block1,5021,5871,6851,8222,2881498679471,0091,036
Accumulated Depreciation8616624733142422230260297337
Net Fixed Assets 1,4151,4211,4381,4911,865127637687711699
CWIP 366511528459035473719
Investments 1,7091,7101,7061,7641,7641,6461,6461,6571,6571,657
Inventories4754545864926560323314251232
Trade Receivables3413864944814250131189194206
Cash Equivalents 417738352584023113613
Others Assets 2882692483174063166879472
Total Assets 4,3064,3824,6254,8645,4331,8452,8602,9912,9802,898

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 164419558182317608-4-65143136
PBT 8611536818329927385794238
Adjustment 260230207159103196-49-354879
Changes in Working Capital -1688042-112-65181-3-926631
Tax Paid -14-5-58-49-20-43-19-17-12-13
Cash Flow From Investing Activity 522-43-127-285-1981789331-40-2
Capex -68-103-141-281-197-92-37-59-67-21
Net Investments 41300001290-9-7-1
Others 1776014-4-1142130993420
Cash Flow From Financing Activity -784-338-47085-41-782-10723-78-157
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -520-156-2860-160-13600100-3
Interest Paid -201-170-138-134-147-102-11-18-30-30
Dividend Paid -51-53-55-56-153-1-80-80-80-80
Others -13419275419-542-16121-68-44
Net Cash Flow -9838-40-18785-18-1225-24

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)3.693.912.286.4312.9811.034.332.061.320.82
ROCE (%)7.137.6413.578.110.111.824.363.672.642.52
Asset Turnover Ratio0.580.60.740.720.610.740.310.280.260.25
PAT to CFO Conversion(x)2.255.32.121.230.992.84-0.05-1.34.477.16
Working Capital Days
Receivable Days4351485253066728998
Inventory Days65655757670163143131118
Payable Days1101191271201328096142161201

Jubilant Pharmova Ltd Stock News

Jubilant Pharmova Ltd FAQs

The current trading price of Jubilant Pharmova on 05-Dec-2025 16:59 is ₹1,076.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Jubilant Pharmova stood at ₹17,030.3.
The latest P/E ratio of Jubilant Pharmova as of 04-Dec-2025 is 0.00.
The latest P/B ratio of Jubilant Pharmova as of 04-Dec-2025 is 7.59.
The 52-week high of Jubilant Pharmova is ₹1,250 and the 52-week low is ₹823.7.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Jubilant Pharmova is ₹534.5 ( Cr.) .

About Jubilant Pharmova Ltd

Jubilant Life Sciences (formerly Jubilant Organosys) was incorporated in the year 1978. It’s a public limited company domiciled in India and incorporated under the provisions of Companies Act, 1956. Its shares are listed on BSE Limited and National Stock Exchange of India Limited.

The Pharmaceuticals segment, through its wholly-owned subsidiary Jubilant Pharma Limited, is engaged in manufacturing and supply of APIs, solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through six USFDA approved manufacturing facilities in the US, Canada and India and a network of various radiopharmacies in the US.

The Life Science Ingredients segment is engaged in specialty intermediates, nutritional products and life science chemicals through five manufacturing facilities in India. The drug discovery solutions business is served by Jubilant Biosys and the India branded pharmaceuticals business is an Indian venture with a range of pharmaceutical offerings for the domestic market, focusing primarily on products to treat medical conditions in the field of cardiology and diabetology.

Business area of the company

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients, drug discovery solutions and India branded pharmaceuticals.

Business segments

  • Pharmaceuticals
  • Life Science Ingredients
  • Drug Discovery & Development Solutions
  • India Branded Pharmaceuticals

Awards

2012

  • NDTV Profit Business Leadership Award 2012 for Corporate Social Responsibility. National Quality Excellence Award for best in Class manufacturing presented by Stars of the Industry Group.CII ‘National Award for Excellence in Water Management 2012’ as ‘Water Efficient Unit’ for Gajraula Unit.
  • Economic Times - Frost & Sullivan India Manufacturing Excellence Gold Award - Process Sector for 2012. I.C.C. Award for Water Resource Management in Chemical Industry for the year 2011.

2013

  • Jubilant Life Sciences Awarded ‘Excellence Award’ by Export Promotion Bureau.
  • Jubilant Life Sciences declared winner of ‘Supply Chain Excellence Awards’ at 7th Express, Logistics & Supply Chain Leadership Awards 2013.
  • Jubilant Life Sciences receives prestigious NDTV Profit Business Leadership Award 2012 for Corporate ‘Social Responsibility’.

2014

  • Jubilant Life Sciences wins Excellence Awards at ‘India Pharma Awards’ 2014.
  • BRI Partners with Jubilant Life Sciences to Bring XylamaxTM to the South Asia Poultry Market.
  • Jubilant Life Sciences conferred with Golden Peacock Business Excellence Award-2014.
  • Jubilant Biosys and Orion Corporation Announces Unique Collaborative Discovery Program in Pain Management Area.
  • IDRI and Jubilant Chemsys Extend Research for TB Drug Discovery.
  • Jubilant Life Sciences declared winner of 'Bio Excellence Award 2014' at Bangalore India Bio 2014.
  • Jubilant Biosys Announces Expansion of Drug Discovery Alliance with Janssen Pharmaceutical.

2015

  • Jubilant Life Sciences conferred with Golden Peacock National Quality Award.
  • Jubilant Life Sciences wins ASSOCHAM’s ‘Responsible Organization Excellence’ Award 2014-15.

2016

  • Sustainability Award for Best Green Process in ‘Chemical Sector’ by ‘FICCI Chemicals & Petrochemicals Awards, 2016’.
  • Winner of two CHEMEXCIL Export Awards: Trishul Export Award 2012-13 and Gold Export Award 2011-12.
  • 16th Annual Greentech Environment Award 2015 (Gold Category), conferred under ‘Chemicals and Pharmaceutical sector’ - Gajraula plant, India.

2017

  • Social Entrepreneur of the Year (SEOY)-India Award 2017.
  • Finalists for Social Entrepreneur of the Year (SEOY) India 2017 Award.
  • ‘Second Awards’ under the category of Basic Inorganic, Organic Chemicals including Agro Chemicals for the outstanding export performance of the year 2015-16 by CHEMEXCIL.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×